Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

DAWNDAWN
Showing 8 of 20 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in DAY ONE BIOPHARMACEUTICALS I

WELLS FARGO & COMPANY/MN previously held 0 shares of DAWN (DAY ONE BIOPHARMACEUTICALS I), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$786,752

Total Shares Change

-56,479

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$21.45
0
2026-Q1
Decreased
56,429
-50.8%
$1.2M0.0%$10.03
0
2025-Q4
Increased
114,716
+40.8%
$1.1M0.0%$9.18
33
2025-Q3
Increased
81,468
+12.3%
$574,3500.0%$6.99
27
2025-Q2
Increased
72,567
+35.1%
$471,6860.0%$6.47
31
2025-Q1
Increased
53,696
+3.8%
$425,8090.0%$8.07
25
2024-Q4
Decreased
51,735
-8.4%
$655,4830.0%$12.58
0
2024-Q3
Decreased
56,479
-0.8%
$786,7520.0%$14.16
0

Other major holders of DAWN: FMR LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used